Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology | Family Medicine
Disease Category: Depression
Location: United States, UT

Clinical Trial Details

Overview

Research Study Summary

Depression

Purpose

A Phase 3, Randomized, Double-Blind, parallel-group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of LuAA21004 in Acute treatent of Adults with Major Depressive Disorder.

Patient Inclusion Criteria:

  • Male or Females ages 18 to 75
  • Recurrent Major Depressive Episode

Patient Exclusion Criteria:

  • Any current psychiatric disorder other than MDD
  • Current or past manic or hypomanic schizophrenia or other psychotic disorder

To Learn more
Phase

3

Gender

Both Male and Female

Age

18 to 75 Years

Overall Status

Recruiting

Facility Type

N/A

Contact

Cher Struck, Director Marketing and Recruiting
Lifetree Clinical Research
3838 South 700 East Suite 202
Salt Lake CIty, UT 84106
Phone: 801-269-8200

View Map

Research Center Information: Lifetree Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 180849

Date Last Changed: July 19, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.